FR2670797B1 - - Google Patents

Info

Publication number
FR2670797B1
FR2670797B1 FR9016044A FR9016044A FR2670797B1 FR 2670797 B1 FR2670797 B1 FR 2670797B1 FR 9016044 A FR9016044 A FR 9016044A FR 9016044 A FR9016044 A FR 9016044A FR 2670797 B1 FR2670797 B1 FR 2670797B1
Authority
FR
France
Prior art keywords
pct
sec
date
hpv
pub
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9016044A
Other languages
English (en)
French (fr)
Other versions
FR2670797A1 (fr
Inventor
Gerard Orth
Christoph Volpers
Rolf Streeck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur
Original Assignee
Institut Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9016044A priority Critical patent/FR2670797A1/fr
Application filed by Institut Pasteur filed Critical Institut Pasteur
Priority to DK92903034.4T priority patent/DK0563255T3/da
Priority to CA002375673A priority patent/CA2375673C/fr
Priority to JP50307192A priority patent/JP3859696B2/ja
Priority to ES92903034T priority patent/ES2062887T3/es
Priority to US08/074,879 priority patent/US5656423A/en
Priority to DE69104380T priority patent/DE69104380T2/de
Priority to AT92903034T priority patent/ATE112316T1/de
Priority to PCT/FR1991/001053 priority patent/WO1992011369A1/fr
Priority to EP92903034A priority patent/EP0563255B1/fr
Priority to CA002098819A priority patent/CA2098819C/fr
Publication of FR2670797A1 publication Critical patent/FR2670797A1/fr
Application granted granted Critical
Publication of FR2670797B1 publication Critical patent/FR2670797B1/fr
Priority to US08/468,057 priority patent/US5665535A/en
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/084—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR9016044A 1990-12-20 1990-12-20 Sequences d'adn determinees derivees du genome du papillomavirus hpv39, application de ces sequences au diagnostic in vitro d'infection par ce papillomavirus, et a la production de composition immunogene. Granted FR2670797A1 (fr)

Priority Applications (12)

Application Number Priority Date Filing Date Title
FR9016044A FR2670797A1 (fr) 1990-12-20 1990-12-20 Sequences d'adn determinees derivees du genome du papillomavirus hpv39, application de ces sequences au diagnostic in vitro d'infection par ce papillomavirus, et a la production de composition immunogene.
PCT/FR1991/001053 WO1992011369A1 (fr) 1990-12-20 1991-12-20 Sequences d'adn derivees du genome du papillomavirus hpv39, leur application au diagnostic in vitro et a la production de composition immunogene
JP50307192A JP3859696B2 (ja) 1990-12-20 1991-12-20 乳頭腫ウイルスｈｐｖ３９のゲノムから誘導されるｄｎａ配列、ｉｎ ｖｉｔｒｏ診断及び免疫原組成物の生成への前記配列の応用
ES92903034T ES2062887T3 (es) 1990-12-20 1991-12-20 Secuencias de adn derivadas del genoma del papilomavirus hpv39, su aplicacion al diagnostico in vitro y a la produccion de preparado inmunogeno.
US08/074,879 US5656423A (en) 1990-12-20 1991-12-20 DNA sequences derived from the genome of the papillomavirus HPV39, their use in in vitro diagnosis and for the production of an immunogenic composition
DE69104380T DE69104380T2 (de) 1990-12-20 1991-12-20 Vom genom des papillomavirus-hpv-39 abgeleitete dns-sequenzen, deren anwendung in der in vitro-diagnose und zur herstellung einer immunogenenzusammensetzung.
DK92903034.4T DK0563255T3 (da) 1990-12-20 1991-12-20 DNA-sekvenser afledt af genomet fra papillomavirus HPV39, anvendelse heraf til in vitro-diagnostik og til fremstilling af immunogent præparat
CA002375673A CA2375673C (fr) 1990-12-20 1991-12-20 Sequences d'adn derivees du genome du papillomavirus hpv39, leur application au diagnostic in vitro et a la production de composition immunogene
EP92903034A EP0563255B1 (fr) 1990-12-20 1991-12-20 Sequences d'adn derivees du genome du papillomavirus hpv39, leur application au diagnostic in vitro et a la production de composition immunogene
CA002098819A CA2098819C (fr) 1990-12-20 1991-12-20 Sequences d'adn derivees du genome du papillomavirus hpv39, leur application au diagnostic in vitro et a la production de composition immunogene
AT92903034T ATE112316T1 (de) 1990-12-20 1991-12-20 Vom genom des papillomavirus-hpv-39 abgeleitete dns-sequenzen, deren anwendung in der in vitro- diagnose und zur herstellung einer immunogenenzusammensetzung.
US08/468,057 US5665535A (en) 1990-12-20 1995-06-06 Polypeptides encoded by DNA sequences derived from the genome of the papillomavirus HPV39, antibodies thereto, and their use in in vitro diagnosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9016044A FR2670797A1 (fr) 1990-12-20 1990-12-20 Sequences d'adn determinees derivees du genome du papillomavirus hpv39, application de ces sequences au diagnostic in vitro d'infection par ce papillomavirus, et a la production de composition immunogene.

Publications (2)

Publication Number Publication Date
FR2670797A1 FR2670797A1 (fr) 1992-06-26
FR2670797B1 true FR2670797B1 (enExample) 1994-08-19

Family

ID=9403488

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9016044A Granted FR2670797A1 (fr) 1990-12-20 1990-12-20 Sequences d'adn determinees derivees du genome du papillomavirus hpv39, application de ces sequences au diagnostic in vitro d'infection par ce papillomavirus, et a la production de composition immunogene.

Country Status (10)

Country Link
US (2) US5656423A (enExample)
EP (1) EP0563255B1 (enExample)
JP (1) JP3859696B2 (enExample)
AT (1) ATE112316T1 (enExample)
CA (2) CA2098819C (enExample)
DE (1) DE69104380T2 (enExample)
DK (1) DK0563255T3 (enExample)
ES (1) ES2062887T3 (enExample)
FR (1) FR2670797A1 (enExample)
WO (1) WO1992011369A1 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639871A (en) * 1988-09-09 1997-06-17 Roche Molecular Systems, Inc. Detection of human papillomavirus by the polymerase chain reaction
GB9621091D0 (en) 1996-10-09 1996-11-27 Fondation Pour Le Perfectionem Attenuated microorganisms strains and their uses
CA2348413C (en) * 1998-10-26 2008-12-30 Ventana Medical Systems, Inc. Detection of human papilloma virus in papanicolaou (pap) smears
US7569344B2 (en) * 1998-10-26 2009-08-04 Ventana Medical Systems, Inc. Detection of human papilloma virus in papanicolaou (Pap) smears
CA2365901A1 (en) * 1999-04-14 2000-10-19 Musc Foundation For Research Development Tissue-specific and pathogen-specific toxic agents and ribozymes
US20060275784A1 (en) * 1999-10-26 2006-12-07 Ventana Medical Systems, Inc. Detection of Human Papilloma Virus in Papanicolaou (Pap) Smears
US20040229298A1 (en) * 2000-11-11 2004-11-18 Lu Peter S. Methods and compositions for treating cervical cancer
US7312041B2 (en) * 2001-02-16 2007-12-25 Arbor Vita Corporation Methods of diagnosing cervical cancer
JP2004535816A (ja) * 2001-07-20 2004-12-02 ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム Ｃｉｎを含むｈｐｖ関連の前癌性増殖および癌性増殖に関する方法および組成物
WO2004002416A2 (en) * 2002-06-26 2004-01-08 The Penn State Research Foundation Methods and materials for treating human papillomavirus infections
CA2495449A1 (en) 2002-09-09 2004-03-18 Arbor Vita Corporation Methods of diagnosing cervical cancer
AU2004275865B2 (en) 2003-09-25 2008-09-25 Third Wave Technologies, Inc. Detection of HPV
EP1708745B1 (en) * 2003-12-23 2012-04-18 Arbor Vita Corporation Antibodies for oncogenic strains of hpv and methods of their use
US7354719B2 (en) 2004-12-08 2008-04-08 Gen-Probe Incorporated Detection of nucleic acids from multiple types of human papillomaviruses
NZ554229A (en) * 2004-12-10 2009-03-31 Genera Biosystems Pty Ltd Human papilloma virus (HPV) detection using nucleic acid probes, microbeads and fluorescent-activated cell sorter (FACS)
US7732166B2 (en) * 2005-11-15 2010-06-08 Oncohealth Corporation Detection method for human pappilomavirus (HPV) and its application in cervical cancer
US7972776B2 (en) * 2005-11-15 2011-07-05 Oncohealth Corporation Protein chips for HPV detection
US8080643B2 (en) * 2006-09-05 2011-12-20 Third Wave Technologies, Inc. HPV primers
US8968995B2 (en) * 2008-11-12 2015-03-03 Oncohealth Corp. Detection, screening, and diagnosis of HPV-associated cancers
US8859218B2 (en) 2008-06-13 2014-10-14 Oncohealth Corp. In situ detection of early stages and late stages HPV infection
CN101730847B (zh) * 2007-04-05 2015-03-18 分类生物系统有限公司 组合物及检测方法
GB0820822D0 (en) * 2008-11-13 2008-12-24 Inst Catala D Oncologia Novel product and processes
EP2427763A4 (en) 2009-05-07 2013-08-21 Oncohealth Corp IDENTIFICATION OF HIGH GRADE OR CIN2 FOR DETECTION, MONITORING AND DIAGNOSIS, AT EARLY STAGES AND ADVANCED STAGES, OF HUMAN PAPILLOMAVIRUS (HPV) AND HPV ASSOCIATED CANCERS
EP2521914A4 (en) 2010-01-08 2013-07-10 Oncohealth Corp CELL-BASED HPV IMMUNOTESTS HAVE A HIGH PERFORMANCE FOR DIAGNOSIS AND SCANNING OF HPV ASSOCIATED CANCER
EP2576840B1 (en) * 2010-05-25 2018-10-17 QIAGEN Gaithersburg, Inc. Fast results hybrid capture assay and associated strategically-truncated probes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2593828B2 (fr) * 1986-01-31 1990-05-04 Pasteur Institut Sonde a papillomavirus et procede de diagnostic in-vitro d'infections a papillomavirus
FR2629458B2 (fr) * 1987-07-31 1991-08-09 Ire Celltarg Sa Nouvelles sondes d'acides nucleiques specifiques de differents types de virus de papillome humain
US5447839A (en) * 1988-09-09 1995-09-05 Hoffmann-La Roche Inc. Detection of human papillomavirus by the polymerase chain reaction
US5182377A (en) * 1988-09-09 1993-01-26 Hoffmann-La Roche Inc. Probes for detection of human papillomavirus
FR2641081A1 (enExample) * 1988-12-23 1990-06-29 Medgenix Group

Also Published As

Publication number Publication date
DK0563255T3 (da) 1994-10-24
ES2062887T3 (es) 1994-12-16
DE69104380T2 (de) 1995-02-09
CA2375673A1 (fr) 1992-07-09
FR2670797A1 (fr) 1992-06-26
DE69104380D1 (de) 1994-11-03
CA2375673C (fr) 2005-05-17
JP3859696B2 (ja) 2006-12-20
JPH06504672A (ja) 1994-06-02
ATE112316T1 (de) 1994-10-15
WO1992011369A1 (fr) 1992-07-09
EP0563255A1 (fr) 1993-10-06
US5656423A (en) 1997-08-12
EP0563255B1 (fr) 1994-09-28
US5665535A (en) 1997-09-09
CA2098819A1 (fr) 1992-06-21
CA2098819C (fr) 2002-06-18

Similar Documents

Publication Publication Date Title
FR2670797B1 (enExample)
GB9015845D0 (en) Diagnostic method
FI875082A0 (fi) Dna-sekvensser deriverade fraon genom av papillomavirus, deras anvaendning foer in vitro diagnostiska aendamaol; samt framstaellning av antigeniska kompositioner.
DK0675956T3 (da) Nyt protein fra urin betegnet komponent B
DE69307495D1 (en) Oligothionukleotide
CA2230967A1 (en) Improved nucleic acid assays
ATE121794T1 (de) Verfahren zum nachweis des karzinogenen menschlichen papillomavirus.
ATE552340T1 (de) Hepatitis c virus genotypsequenzen sowie ihre verwendung als behandlungs- und nachweismitteln
AU2022295A (en) Nucleic acid amplification with DNA-dependant RNA polymerase activity of RNA replicases
DE69332642D1 (de) Methoden zur detektion von mikrometastasen bei prostata-krebs
DE68922336D1 (de) Sonden für Papilloma-Virus (HPV49, HPV50, HPV54, HPV55), zu diesem Papilloma-Virus genetisch und immunologisch verwandte Produkte und in vitro Methoden zur Diagnose von Papilloma-Virusinfektionen und Herstellung von Antikörpern gegen diese Papilloma-Viren.
PT83255A (en) Process for the preparation of polypeptides and characteristic antibodies of papillomavirus and diagnostic method thereto
DK0477972T3 (enExample)
ES2123000T3 (es) Secuencias de adn del papilomavirus hpv 42 y su aplicacion en diagnostico.
TR199801039T2 (xx) Yeni fenilamidin t�revlerinin elde edilmesine y�nelik usul.
EP0178845A3 (en) Peptide-substituted heterocyclic immunostimulants
FI893683A0 (fi) Ihmisen papilloomavirus tyyppi 57, sen eristetty DNA ja näiden käyttö
DK0779895T3 (da) Forbedret fremgangsmåde til fremstilling af sidekædederivater af cyclohexapeptidyl-lipopeptider
ES2093554A1 (es) Procedimientos de amplificacion de genoma y mezclas de oligonucleotidos iniciadores para la deteccion y la identificacion de agentes infecciosos relacionados.
ES2048652B1 (es) Procedimientos de amplificacion de genoma para la deteccion e identificacion de secuencias genomicas relacionadas.
WO2001027330A3 (en) Screening for disease susceptibility by genotyping the ccr5 and ccr2 genes
EP1309342A4 (en) PREPARATION OF A CHIMERIC PAPILLOMA VIRUS (22.01.2)
TR199700863A2 (xx) Paklitaksel haz�rlama prosesi.
MY128619A (en) Detection of human hepatitis b virus surface antigen mutants by specific amplification and its application on gene chip
WO1993002217A3 (fr) Sondes oligonucleotidiques pour le typage et la detection des papillomavirus humains

Legal Events

Date Code Title Description
TP Transmission of property